Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E- dependent upregulation of Fcε receptor I expression

Journal of Experimental Medicine

Volumn 188, Issue 6, 1998, Pages 1135-1145

  Boesiger, Jürg ^a   Tsai, Mindy ^a   Maurer, Marcus ^a   Yamaguchi, Masao ^a   Brown, Lawrence F ^a   Claffey, Kevin P ^a   Dvorak, Harold F ^a   Galli, Stephen J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Allergy; Angiogenesis; C kit; Stem cell factor; Vascular permeability

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN E; STEM CELL FACTOR; VASCULOTROPIN;

ALLERGY; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; CALCIMYCIN; CELL LINE; CELLS, CULTURED; DINITROPHENOLS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HAPTENS; HUMANS; IMMUNOGLOBULIN E; LYMPHOKINES; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; RATS; RATS, WISTAR; RECEPTORS, IGE; RNA, MESSENGER; SERUM ALBUMIN; STEM CELL FACTOR; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; UMBILICAL CORD; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032555946     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.6.1135     Document Type: Article

References (43)

1. Selye, H. 1965. The Mast Cells. Butterworth Inc., Washington, DC. 488 pp.
2. Galli, S.J., K.M. Zsebo, and E.N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55:1-96.
3. Glowacki, J., and J.B. Mulliken. 1982. Mast cells in hemangiomas and vascular malformations. Pediatrics. 70:48-51.
4. Lauria de Cidre, L., and E. Sacerdote de Lustig. 1990. Mast cell kinetics during tumor growth. Tumor Biol. 11:196-201.
5. v mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer. 42:48-52.
6. Mican, J.M., and D.D. Metcalfe. 1990. Arthritis and mast cell activation. J. Allergy Clin. Immunol. 86:677-683.
7. Trabucchi, E., E. Radaelli, M. Marazzi, D. Foschi, M. Musazzi, A.M. Veronesi, and W. Montorsi. 1988. The role of mast cells in wound healing. Int. J. Tissue React. 10:367-372.
8. Krishna, A., K. Beesley, and P.F. Terranova. 1989. Histamine, mast cells and ovarian function. J. Endocrinol. 120:363-371.
9. Folkman, J. 1985. Regulation of angiogenesis: a new function of heparin. Biochem. Pharmacol. 34:905-909.
10. Azizkhan, R.G., J.C. Azizkhan, B.R. Zetter, and J. Folkman. 1980. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J. Exp. Med. 152:931-944.
11. Gordon, J.R., and S.J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174:103-107.
12. Gordon, J.R., and S.J. Galli. 1994. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI. Role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J. Exp. Med. 180:2027-2037.
13. Qu, Z., J.M. Liebler, M.R. Powers, T. Galey, P. Ahmadi, X.N. Huang, J.C. Ansel, J.H. Butterfield, S.R. Planck, and J.T. Rosenbaum. 1995. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am. J. Pathol. 147:564-573.
14. Blair, R.J., H. Meng, M.J. Marchese, S. Ren, L.B. Schwartz, M.G. Tonnesen, and B.L. Gruber. 1997. Human mast cells stimulate vascular tube formation. J. Clin. Invest. 99:2691-2700.
15. Dvorak, H.F., L.F. Brown, M. Detmar, and A.M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1039.
16. Ferrara, N., and T. Davis-Smyth. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25.
17. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K.S. O'Shea, L. Powell-Braxton, K.J. Hillan, and M.W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:439-442.
18. Pierce, E.A., R.L. Avery, E.D. Foley, L.P. Aiello, and L.E. Smith. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA. 92:905-909.
19. Senger, D.R., S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:983-985.
20. Senger, D.R., L. Van De Water, L.F. Brown, J.A. Nagy, K.-T. Yeo, T.-K. Yeo, B. Berse, R.W. Jackman, A.M. Dvorak, and H.F. Dvorak. 1993. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:303-324.
21. Brown, L.F., M. Detmar, K. Claffey, J.A. Nagy, D. Feng, A.M. Dvorak, and H.F. Dvorak. 1997. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In Regulation of Angiogenesis. I.D. Goldberg and E.M. Rosen, editors. Birkhaeuser Verlag, Basel. 233-269.
22. Yamaguchi, M., C.S. Lantz, H.C. Oettgen, I.M. Katona, T. Fleming, I. Miyajima, J.-P. Kinet, and S.J. Galli. 1997. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 185:663-672.
23. Yano, K., M. Yamaguchi, F. de Mora, C.S. Lantz, J.H. Butterfield, J.J. Costa, and S.J. Galli. 1997. Production of macrophage inflammatory protein-1α by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab. Invest. 77: 185-193.
24. Tsai, M., M. Miyamoto, S.Y. Tam, Z.S. Wang, and S.J. Galli. 1995. Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am. J. Pathol. 146:335-343.
25. Young, J.D., C.C. Liu, G. Butler, Z.A. Cohn, and S.J. Galli. 1987. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 84:9175-9179.
26. Tsai, M., J. Hunt, J.P. Arm, C. London, M. Gunsh, and S.J. Galli. 1996. The Cl.MC/C57.1 (C57) mouse mast cell line is of BALB/c origin and is tumorigenic in BALB/c mice. FASEB J. 10:1268a.(Abstr.)
27. Gagari, E., M. Tsai, C.S. Lantz, L.G. Fox, and S.J. Galli. 1997. Differential release of mast cell interleukin-6 via c-kit. Blood. 89:2654-2663.
28. Taylor, A.M., S.J. Galli, and J.W. Coleman. 1995. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology. 86: 427-433.
29. Liu, F.T., J.W. Bohn, E.L. Ferry, H. Yamamoto, C.A. Molinaro, L.A. Sherman, N.R. Klinman, and D.H. Katz. 1980. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J. Immunol. 124: 2728-2737.
30. Claffey, K.P., W.O. Wilkison, and B.M. Spiegelman. 1992. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267:16317-16322.
31. Brown, L.F., K.-T. Yeo, B. Berse, T.-K. Yeo, D.R. Senger, H.F. Dvorak, and L. Van De Water. 1992. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176:1375-1379.
32. ffrench-Constant, C., L. Van De Water, H.F. Dvorak, and R.O. Haynes. 1989. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 109:903-914.
33. Nagy, J.A., E.M. Masse, K.T. Herxberg, M.S. Meyers, K.-T. Yeo, T.-K. Yeo, T.M. Sioussat, and H.F. Dvorak. 1995. Pathogenesis of ascites tumor growth. Vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Res. 55:360-368.
34. Cullinan-Bove, K., and R.D. Koos. 1993. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 133:829-837.
35. Conn, G., M.L. Bayne, D.D. Soderman, P.W. Kwok, K.A. Sullivan, T.M. Palisi, D.A. Hope, and K.A. Thomas. 1990. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 87:2628-2632.
36. Minchenko, A., T. Bauer, S. Salceda, and J. Caro. 1994. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71:374-379.
37. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268:1749-1756.
38. Cohen, T., D. Nahari, L.W. Cerem, G. Neufeld, and B.Z. Levi. 1996. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271:736-741.
39. Pertovaara, L., A. Kaipainen, T. Mustonen, A. Orpana, N. Ferrara, O. Saksela, and K. Alitalo. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269:6271-6274.
40. Baumgartner, R.A., K. Yamada, V.A. Deramo, and M.A. Beaven. 1994. Secretion of TNF from a rat mast cell line is a brefeldin a-sensitive and a calcium/protein kinase C-regulated process. J. Immunol. 153:2609-2617.
41. Holgate, S.T., S. Robinson, and M.K. Church. 1993. Mediators of immediate hypersensitivity. In Allergy Principles and Practice, 4th ed. E. Middleton, Jr., C.E. Reed, E. Ellis, N.F. Adkinson, J.W. Yuninger, and W.W. Busse, editors. Mosby-Year Book, Inc., Boston. 267-301.
42. 206. Mol. Biol. Cell. 9:875-884.
43. Soter, N.A. 1991. The skin in mastocytosis.J. Investig. Dermatol. 3:32S-38S.